Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -2.13x is 77% above its 5-year average of -9.15x, near the high end of its 5-year range (-55.54x–13.58x).
154.48% below its 12-month average of 3.91x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 13.58x.
INTEREST COVERAGE RATIO
-2.13x
INTEREST COVERAGE RATIO AVG TTM
3.91x
INTEREST COVERAGE RATIO AVG 3Y
-5.07x
INTEREST COVERAGE RATIO AVG 5Y
-9.15x
INTEREST COVERAGE RATIO AVG 10Y
-19.50x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-154.48%
CURRENT VS 3Y AVG
+57.96%
CURRENT VS 5Y AVG
+76.72%
CURRENT VS 10Y AVG
+89.07%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+66.59%
vs the sector median at left
Liquidia Corporation
Market Cap
$2.30B
Interest Coverage Ratio
-2.13x
TTM Avg
3.91x
3Y Avg
-5.07x
5Y Avg
-9.15x
Market Cap
$2.28B
Interest Coverage Ratio
14.23x
TTM Avg
12.57x
3Y Avg
9.90x
5Y Avg
7.30x
Market Cap
$2.33B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.33B
Interest Coverage Ratio
9.42x
TTM Avg
9.73x
3Y Avg
13.83x
5Y Avg
133.49x
Market Cap
$2.34B
Interest Coverage Ratio
26.93x
TTM Avg
18.45x
3Y Avg
12.59x
5Y Avg
12.59x
Market Cap
$2.23B
Interest Coverage Ratio
-78.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.37B
Interest Coverage Ratio
-65.43x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.20B
Interest Coverage Ratio
-0.25x
TTM Avg
23.23x
3Y Avg
12.79x
5Y Avg
10.35x
Market Cap
$2.40B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Liquidia Corporation (LQDA) | $2.30B | -2.13x | 3.91x | -5.07x | -9.15x |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.28B | 14.23x | 12.57x | 9.90x | 7.30x |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.33B | N/A | N/A | N/A | N/A |
| UFP Technologies, Inc. (UFPT)vs › | $2.33B | 9.42x | 9.73x | 13.83x | 133.49x |
| ADMA Biologics, Inc. (ADMA)vs › | $2.34B | 26.93x | 18.45x | 12.59x | 12.59x |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.23B | -78.14x | N/A | N/A | N/A |
| Disc Medicine, Inc. (IRON)vs › | $2.37B | -65.43x | N/A | N/A | N/A |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.20B | -0.25x | 23.23x | 12.79x | 10.35x |
| Clover Health Investments, Corp. (CLOV)vs › | $2.40B | N/A | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.41B | -358.08x | N/A | N/A | N/A |
Interest Coverage
-2.1x
Debt/Equity
0.66
Current Ratio
2.31
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 13.58x |
| 2026-03-31 | 9.47x |
| 2025-12-31 | 2.87x |
| 2025-09-30 | 0.25x |
| 2025-06-30 | -6.63x |
| 2025-03-31 | -7.59x |
| 2024-12-31 | -8.27x |
| 2024-09-30 | -9.74x |
| 2024-06-30 | -10.46x |
| 2024-03-31 | -11.41x |
| 2023-12-31 | -13.47x |
| 2023-09-30 | -8.46x |
| 2023-06-30 | -16.01x |
| 2023-03-31 | -8.21x |
| 2022-12-31 | -9.31x |
| 2022-09-30 | -14.24x |
| 2022-06-30 | -16.55x |
| 2022-03-31 | -30.28x |
| 2021-12-31 | -55.54x |
| 2021-09-30 | -34.54x |
| 2021-06-30 | -31.30x |
| 2021-03-31 | -60.01x |
| 2020-12-31 | -78.99x |
| 2020-09-30 | -77.74x |
| 2020-06-30 | -64.99x |
| 2020-03-31 | -57.45x |
| 2019-12-31 | -21.93x |
| 2019-09-30 | -50.26x |
| 2019-06-30 | -23.13x |
| 2019-03-31 | -62.58x |
| 2018-12-31 | -42.60x |
| 2018-09-30 | -14.56x |
| 2018-06-30 | -28.33x |
| 2018-03-31 | -0.50x |
| 2017-12-31 | -1.53x |
| 2017-09-30 | -1.88x |
| 2017-06-30 | -3.27x |
| 2017-03-31 | -3.01x |
